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ABSTRACT 
 
FACTORS ASSOCIATED WITH  INFLUENZA VACCINE UPTAKE AMONG PREGNANT WOMEN: 
ANALYSIS OF THE 2015 GEORGIA VITAL EVENTS INFORMATION SYSTEM BIRTH WORKSHEET 
 
by 
 
ELIZABETH M. GRABOWSKI 
 
JULY 12TH, 2017 
 
 
INTRODUCTION: Influenza is a public health concern each influenza season in the United States 
(US). Annually, about 50,000 people die due to influenza complications in the US. Pregnant 
women and children under the age of five are two of the most at-risk groups for influenza-
related morbidity and mortality. Since 2004, the Centers for Disease Control (CDC), the Advisory 
Committee on Immunization Practice (ACIP), and the American College of Obstetricians and 
Gynecologists (ACOG) have recommended that women who will be pregnant during the 
influenza season get vaccinated. Vaccination of mothers also protects infants for up to the first 
six months of life through the active transfer of maternal antibodies in the womb. Vaccination 
during pregnancy is safe and is the most effective way for mothers to protect themselves and 
their infants from the influenza virus. 
 
PURPOSE: Vaccination rates among pregnant women in Georgia are low, despite the CDC, ACIP, 
and ACOG recommendation to be vaccinated for influenza during pregnancy. In 2013, only 
23.7% of women in Georgia received an influenza vaccine before or during pregnancy, a 
number well below the national average of 55.3% for the same year. The purpose of this study 
is to determine which factors are positively associated with influenza vaccine uptake during 
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pregnancy in Georgia through an analysis of the 2015 Georgia Vital Events Information System 
(VEIS) Birth Worksheet. The author believes that by identifying which factors show an increase 
in vaccine uptake, clinicians will be able to beneficially direct vaccine promotion efforts among 
pregnant women in Georgia.  
 
METHODS: Secondary data from the 2015 VEIS Birth Worksheet was obtained from the Georgia 
Department of Public Health. 130,133 women between the ages of 18 – 49 completed a Birth 
Worksheet in 2015 and were included in the study. Variables used for regression analysis, 
descriptive analysis, and prevalence of vaccine uptake include: age, race, education level, 
perinatal region of residence, and receipt of prenatal care. An extensive review of existing 
literature was also conducted.  
 
RESULTS: The prevalence of influenza vaccine uptake among pregnant women varied across the 
variables. 13.39% of women who completed a Birth Worksheet in 2015 reported that they 
received an influenza vaccine during pregnancy. The prevalence of vaccine uptake was highest 
among white women (65.26%), women between the ages of 25 – 34 (60.16%), women with a 
college degree (51.03%), and women living in the Atlanta perinatal region (44.52%). 
Surprisingly, of all the Atlanta region respondents, only 10.32% received an influenza vaccine 
despite having the largest population of all the regions in Georgia. Almost all women who 
received an influenza vaccine during pregnancy also received prenatal care (98.48%). Of the 
115,443 women who received prenatal care, 14.87% received an influenza vaccine. 
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Introduction  
Background 
 The influenza virus is a public health concern each influenza season in the United States 
(US). Annually, about 50,000 people die because of influenza complications in the US [1]. The 
influenza season typically lasts from October to late spring with different strains circulating 
among the population each season [1]. Influenza is defined as a contagious respiratory illness, 
with the illness ranging from mild to severe [2]. Complications due to influenza can cause  
pregnant women, and infants, to be hospitalized or to visit hospital emergency rooms (ER) [3].  
Pregnant women and children under the age of five are two of the most at-risk groups for 
influenza-related morbidity and mortality [4]. The best way for people, especially pregnant 
women, to protect themselves from influenza is to receive a seasonal influenza vaccination 
before the start of the influenza season [1]. 
Since 2004, the Centers for Disease Control and Prevention (CDC), the Advisory 
Committee on Immunization Practice (ACIP), and the American College of Obstetricians and 
Gynecologists (ACOG) have recommended that women who are pregnant during the influenza 
season get vaccinated [5]. This is because pregnant women are vulnerable to influenza and have 
an increased risk of being hospitalized with severe illness caused by the virus [6]. Infants are 
another vulnerable group that is at-risk for contracting influenza, but infants do not receive an 
influenza vaccine until six months of age. Mothers who receive the vaccine during pregnancy 
will help protect their babies from the influenza virus for the first six months of life [7]. 
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Purpose of Study 
 Vaccination rates among pregnant women are low in Georgia despite the 
recommendation to receive the vaccine during pregnancy. In 2013, only 23.7% of women in 
Georgia received an influenza vaccine before or during pregnancy, a number well below the 
national average of 55.3% for the same year [8]. It is important to understand the factors that 
influence influenza vaccine uptake among pregnant women due to their vulnerability for 
contracting the virus and higher likelihood of being hospitalized with influenza complications. 
The aim of this study is to determine which factors are associated with receipt of the influenza 
vaccine, as recommended, during pregnancy.  
Research Questions 
• What factors are associated with influenza vaccine uptake among pregnant women in 
Georgia?  
• Are women who receive prenatal care likely to receive the influenza vaccine during 
pregnancy?  
• Of Georgia’s six perinatal regions, which have the highest and lowest rates of influenza 
vaccination among pregnant women? 
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Review of the Literature 
Influenza 
 The most severe outcomes of influenza are hospitalization and death [2]. Despite this 
information, only about 50% of pregnant women receive an influenza vaccine in the US.  
 Pregnancy Outcomes. During the 2009-2010 influenza season, 29.8% of pregnant women 
in Georgia, who were told by a healthcare worker that they had influenza, were hospitalized [9]. 
This rate was unnecessarily high because the percentage of pregnant women receiving the 
influenza vaccine during the 2009-2010 season was only 32.1% [10]. Due to changes in the 
immune system, lungs, and heart throughout pregnancy, women who are pregnant are more 
susceptible to severe illness caused by influenza compared to women who are not pregnant [7].  
 Most people who become ill due to the influenza virus recover without any harmful 
outcomes. Unfortunately, influenza-related sequela for at-risk groups such as pregnant women, 
the elderly, young children, and those with chronic diseases include serious illness and death 
[11]. Women who have comorbidities such as asthma, diabetes, or multifetal gestation (twins) 
are at a higher risk of serious illness from influenza [5]. While pregnant women generally 
account for only 1% of the population at any given time, in 2009 they accounted for 5% of U.S. 
influenza related deaths [12]. 
Contracting influenza during pregnancy can have serious effects on a fetus. The CDC [7] 
reports that premature labor and delivery are some of the most serious fetal problems associated 
with influenza-related illness during pregnancy. An infant born premature (before 37 weeks 
gestation) can face a lifetime of health complications including increased rates of mortality, 
breathing issues, learning disabilities, and hearing and vision problems [13]. Fetal congenital 
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abnormalities [14], and a predisposition to otitis media and bacterial pneumonia are also of 
concern for infants born to mothers who had influenza while pregnant [15].  
Influenza Vaccine 
To prevent the aforementioned maladies and increased rates of influenza-related 
mortality, pregnant women, of any trimester, should receive the influenza vaccine as it becomes 
available during the influenza season [16]. The influenza vaccine is modified each year after 
experts assess data to determine which strains of the influenza virus will most likely be 
circulating among the population in the upcoming influenza season. [17]. Vaccines are then 
distributed each fall to pharmacies and healthcare facilities before the start of the influenza 
season. The vaccine is safe for those who are pregnant or breastfeeding [7]. Anyone can obtain 
an influenza vaccine through a healthcare provider, or through a pharmacy or local health 
department without a prescription. If obtained outside of the obstetrical practice, it is important 
for a pregnant woman to inform her obstetrical clinician of vaccine receipt so it can be 
documented in her prenatal record. 
 Recommendations. The trivalent inactivated influenza vaccine is recommended for 
women during pregnancy [3]. The ACIP has recommended vaccination among pregnant women 
since 1990 [14]. Pregnant women should not receive the Live, Attenuated Influenza Vaccine 
(LAIV) [11]. While the inactivated vaccine contains killed virus, the LAIV contains an 
attenuated virus which still has the capability to replicate and may make those who receive it feel 
ill with mild influenza symptoms [11]. The inactivated vaccine is safe for both mother and her 
unborn baby, with the baby being protected from birth up to six months after birth [3] through 
the transfer of maternal antibodies [11]. Maternal antibodies can also be transferred to infants 
through breastmilk [18]. The vaccine has been proven to provide a two-for-one benefit in 
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protecting mothers and infants from influenza [15]. In a retrospective cohort study of 10,225 
mothers who received the influenza vaccine while pregnant, newborns did not have any increase 
of major malformations [5]. The study provides evidence that fetuses are not placed at harm if 
mothers receive the vaccine. Studies that prove vaccine safety are imperative for vaccine uptake 
among women who are pregnant during the influenza season.  
Contraindications. The ACIP lists a few contraindications for the influenza vaccine in 
their 2016-2017 seasonal influenza recommendation report. Those who have had any previous, 
severe allergic reaction to an influenza vaccine should not receive the vaccine [11]. Vaccine 
package inserts state that those who have had precious allergic reactions to egg should not 
receive the vaccine, but the ACIP states that people with egg allergy can receive the vaccine 
provided they are monitored by a healthcare professional following vaccine administration [11].  
Other contraindications are having an allergy to any component of the vaccine, people with 
moderate or severe illness at the time the vaccine is sought, and those who are not at high-risk 
for severe flu complications and who are known to have developed Guillain-Barre syndrome 
(GBS) within 6 weeks after receiving a previous influenza vaccination [19]. If a person does not 
meet any of the contraindication criteria, then it is safe and recommended for him/her to receive 
the influenza vaccine.  
Maternal Outcomes. Seasonal influenza-related hospitalization in healthy pregnant 
women occurs at a rate of 1 to 2 per 1,000; a risk that is 18-fold greater than that for healthy 
women who are not pregnant. [20]. Vaccinated mothers were found to be 36% less likely to 
become ill with influenza symptoms compared to those who did not receive the influenza 
vaccine [15]. The vaccine can reduce the risk of severe flu among pregnant women by about 
50% [21]. 
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Infant Outcomes. Besides protecting women from contracting influenza during 
pregnancy, maternal vaccination has benefits for the growing fetus and infant.  Vaccination 
during pregnancy has a strong protective factor for both fetuses and infants. Stillbirth, neonatal 
death, and premature delivery were significantly decreased among mothers who were vaccinated 
for influenza in Sheffield et al.’s study of 10,225 women [5]. Among women who were 
vaccinated during the first trimester, their infants faced an overall decrease in stillbirth rate and 
there was no association between vaccination and an increase in major malformation rates [5]. A 
retrospective study of 58,000 births was conducted in Australia over the 2012 – 2013 influenza 
season. The researchers found that stillbirth was 51% less likely among those vaccinated 
compared to those who were unvaccinated [22]. Moreover, in a review of 3,000 births following 
influenza immunizations in 2009, Kaiser Permanente found that for every twenty-four women 
who were vaccinated while pregnant, one preterm birth was prevented [20].  
The vaccine is also effective at reducing the rate of infants being hospitalized with 
influenza complications. Immunized mothers give birth to infants who have an eighty-one 
percent risk reduction for influenza-related hospitalizations during their first six months of life 
[22]. The health benefits of receiving an influenza vaccine during pregnancy are evident in the 
numerous studies that have been conducted on vaccine safety and efficacy for both mother and 
child. 
The vaccine given to the mother during pregnancy also protects infants (who do not get 
vaccinated until they are six months of age) through in utero transmission of maternal influenza 
antibodies [3]. Vaccination of infants less than six months is not recommended because it is 
ineffective.. An infant’s immune system will not respond to the influenza vaccine to develop 
protective antibodies [23]. Thus, the first influenza vaccine an infant receives is at six months —
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at which time the infant receives two vaccines several weeks apart [24]. A randomized trial 
conducted in Bangladesh, India, found that vaccinating women during their third trimester of 
pregnancy reduced the rate of confirmed influenza in their infants [15]. Effectiveness at 
preventing influenza among infants whose mothers did receive the vaccine was 63% compared 
to infants whose mothers were not vaccinated [15]. A retrospective cohort study of 7,126 
mother-infant pairs conducted in Australia found that the influenza vaccine is safe for infants 
based on an analysis of birthweights and gestation at birth. McHugh et al. did not discover any 
statistically or clinically significant difference in infant birthweight or gestational age at birth 
among infants whose mothers received the influenza vaccine while pregnant [25].  Low 
birthweight or preterm infants are at-risk of health complications that could last a lifetime. 
Ideally, an infant will weight 2,500 grams or more at birth; anything less than 2,500 grams is 
defined as low-birthweight [26]. McHugh et al.’s findings suggest that the influenza vaccine can 
be administered during any trimester without adverse birth outcomes.  
 Factors that Influence Vaccine Uptake. In 2004, the ACIP removed its first trimester 
restriction and now recommends that women who are pregnant during the influenza season be 
vaccinated during any trimester [14]. This change had a positive impact on influenza vaccine 
uptake during the first trimester among pregnant women; the proportion of women who received 
the vaccine in the first trimester more than doubled from the 2003-2004 to 2004-2005 influenza 
seasons [14]. Pregnancy lasts an average of forty weeks; these weeks are split into three 
trimesters. The first trimester is from weeks zero-thirteen, the second trimester is from weeks 
fourteen to twenty-seven, and the third trimester is from weeks twenty-eight to forty [27]. 
Previously, there was concern that the vaccine might harm fetuses during the first trimester so 
the ACIP did not recommend women to be vaccinated during that trimester. After concerns were 
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unsubstantiated, the ACIP revised its recommendations to include influenza vaccination during 
the first trimester. 
In Sheffield et al.’s study, it was found that women who received the influenza vaccine 
were of higher income and age than women who declined the vaccine [5]. Pregnancy Risk 
Assessment Monitoring System (PRAMS) data for the 2009-2010 season also reveals that as 
maternal age increases, so does receipt of the influenza vaccine [10]. Another predictor that 
influences vaccine uptake is co-morbidities; McHugh et al. found that mothers were 13% more 
likely to be vaccinated if they had any risk-factor or co-morbidity [25]. The CDC reports that 
women are five times more likely to report receipt of the influenza vaccine during pregnancy if 
their healthcare provider offers it to them, compared to women who are not offered vaccination 
from their provider [28]. Women are more likely to believe the vaccine is safe, effective, and 
protective if it is offered by their doctor [22]. Influenza vaccine offers from healthcare providers 
have a significant influence on influenza vaccine uptake. 
Women who have previously received the influenza vaccine are more likely to be 
vaccinated during pregnancy [14]. In addition to these factors, women who will have a longer 
overlap with the influenza season are also more likely to be vaccinated [14]. Women with a 
longer pregnancy overlap acknowledge their risk of contracting the influenza virus and are 
vaccinated at a higher rate than those with shorter overlaps. Meharry et al. discovered that 
women who knew of the influenza vaccine’s two-for-one benefit to protect themselves and their 
infants from the influenza virus were more likely to be vaccinated [3].  
Barriers. A major barrier to influenza vaccination is the concern about the safety of the 
vaccine that is held by both pregnant women and some healthcare employees [5]. These concerns 
are unfounded because no study has yet seen an association between adverse outcomes and 
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influenza vaccination in pregnancy. Some women have a “fear if I do and fear if I don’t” 
mentality about the influenza vaccine [3]. They understand they are more susceptible to the 
influenza virus while pregnant, but are worried that the vaccine could cause harm to themselves 
or their unborn baby [3]. Evidence that shows the influenza vaccine is safe can help promote 
vaccine uptake among pregnant women, reducing morbidity and mortality rates among pregnant 
women and their infants who are too young to be vaccinated [25].  
An analysis of eight years of Georgia PRAMS data found that the most commonly cited 
reason for not receiving an influenza vaccine was “I don’t normally get a flu vaccine” [29]. The 
two other most common reasons cited were “Worried about side effects of vaccination for me” 
and “Worried about harming the baby”, with Hispanic women being the highest proportion of 
women citing the last reason [29]. Those who state they do not need the vaccine sometimes also 
fear the vaccine. They feel that they are healthy and not at-risk for influenza complications so 
they fear the potential the vaccine has to change their health status [3]. Women with this fear do 
not wish to change the status quo, so they do not receive the influenza vaccine during pregnancy.  
Healthcare providers are also barriers to vaccination. If providers do not mention or 
recommend to pregnant women that they should receive the influenza vaccine, women are less 
likely to be vaccinated. Providers have significant influence on women’s decisions while they are 
pregnant [3]. In 2011, 27.1% of women who responded to the Georgia PRAMS survey said that 
they did not receive the influenza vaccine because their provider did not mention it [29]. This 
rate was even higher in 2005 with 54.2% of PRAMS participants citing “Doctor did not mention 
influenza vaccination” [29].  
Cost-effectiveness. Not only does the influenza vaccine decrease the risk of adverse 
maternal and infant outcomes, vaccinating women during pregnancy is cost-effective. Xu et al. 
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found that pregnancy related outpatient visits and hospitalizations of mothers and infants 
decrease when women receive the vaccine during pregnancy [30]. Influenza vaccination of all  
pregnant women can save an average of $107,742,336 in direct maternal and infant medical costs 
a year, in the US [30]. Vaccination of pregnant women is estimated to save 123 quality-adjusted 
life years (QALYS) in a mild influenza season and up to 610 QALYS in a moderately severe 
season in the US [30] . One QALY is equivalent to one year of perfect health. When a person is 
in perfect health, the amount spent on healthcare is less than if they were ill.  
Methods 
Participants and Procedures 
 After excluding those women who gave birth in 2014 because the available data was only 
for the last six months of the year, the sample size of all women who gave birth and completed a 
Georgia Birth Worksheet in 2015 was 130,133 women. All participants were female and their 
ages ranged from 18 to 49 years. Those younger than 18 and older than 49 were excluded from 
the data set. Of the participants, most were white (52.95%), the majority resided in the Atlanta 
perinatal region (57.76%), and 55.12% were in the 25 to 34 years old age range. The mean age of 
participants was 28.26 years (see Table 7). Additional demographic characteristics are located in 
Table 1. A map of Georgia’s counties separated into the six perinatal regions can be found in 
Figure 1.  
 This study used secondary, quantitative data from the Georgia Vital Events Information 
System (VEIS) Birth Worksheet for the entire year of 2015. The VEIS Birth Worksheet is a 
requirement by the Georgia Vital Records Office following the birth of a child and is needed to 
complete legal birth certificates. The four-page worksheet asks questions about the infant’s and 
mother’s health, along with demographic questions [31]. After completing the worksheet, 
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mothers submit it to the Vital Records Office for processing. Beginning July 1st, 2014, the 
question about influenza vaccination during pregnancy was added to the Birth Worksheet. Figure 
2 shows an extract of the Georgia VEIS Birth Worksheet’s question 51.  
Measures  
 Vaccination. The primary vaccination variables were question 51 of the Birth Worksheet: 
influenza vaccination during pregnancy (yes or no) and trimester of vaccination (first, second, or 
third). The variable for influenza vaccination during pregnancy was coded dichotomously for 
analysis; if a respondent answered yes, it was coded to 1 and if a respondent answered no, it was 
coded to 2. The variable for trimester of influenza vaccination was coded 1- first trimester, 2- 
second trimester, and 3- third trimester. 
 Perinatal Region of Residence. The variable for residence was question 21, county of 
residence. All 159 Georgia counties were assigned to their respective Georgia Perinatal Region 
using the map from the Georgia Department of Public Health (Figure 1) as a guide. Counties in 
Alabama, Florida, South Carolina, North Carolina, and Tennessee that border Georgia were 
assigned to their respective Perinatal Region because residents from bordering counties 
commonly seek prenatal care and delivery services in Georgia. Counties from states outside of 
Georgia that do not border the state were assigned as “out-of-state” for analysis purposes.  
 Prenatal Care. The primary variable for prenatal care was question 53 a, Did mother 
receive prenatal care? Responses were yes, no, or unknown. These responses were coded as 1- 
yes, 2- no, and 3- unknown.  
Demographics. Demographic variables used in this study were mother’s race (Asian, 
Black/African American, Hawaiian/Pacific Islander, White, American Indian/Alaskan Native, 
other, and unknown), mother’s age at time of infant’s birth (18 - 20, 21 - 24, 25 - 34, 35 - 49 
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years), and mother’s education level (less than high school degree, high school degree/GED, 
college degree, and unknown).  
For the purposes of this study, the independent variables of interest are mother’s age at 
time of birth, mother’s race, mother’s education level, did the mother receive prenatal care 
during pregnancy, and mother’s perinatal region of residence. The dependent variables of interest 
are influenza vaccination during pregnancy and trimester of vaccination.  
Statistical Analysis 
All data analyses were performed using Microsoft Excel 2016 Data Analysis ToolPak. 
Regression analysis was performed to evaluate the association of age, education level, perinatal 
region of residence, race, and prenatal care on vaccination receipt. The descriptive statistics 
procedure was used to conduct univariate analysis to determine mother’s mean age at time of 
infant’s birth. Pearson correlation coefficient was conducted to determine the strength of the 
relationship between mother’s age and receipt of influenza vaccine.  
Results 
 The prevalence of influenza vaccination uptake among pregnant women varied across the 
demographic variables found in Table 2. 17,428 women reported that they received an influenza 
vaccine during their pregnancy in 2015 (13.39% of all Birth Worksheet respondents). Of those 
17,428 women, 65.26% were white, 60.16% were 25 - 34 years of age, 44.52% resided in the 
Atlanta perinatal region, and 51.03% had a college degree. Almost all women who received an 
influenza vaccine also received prenatal care (98.48%).  
 Of the total sample population, 88.71% received prenatal care during pregnancy (Table 
3). 14.87% of women who received prenatal care also received an influenza vaccine. Vaccine 
uptake among women who received prenatal care varied across trimesters (Table 4). 27.78% of 
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women who received prenatal care received the vaccine during the first trimester, 34.44% 
received the vaccine during the second trimester, and 35.68%, received the vaccine during the 
third and final trimester of pregnancy.  
 Influenza vaccination uptake by perinatal region of residence was examined next (Table 
5). Of the six perinatal regions in Georgia, the Atlanta region had the highest percentage of 
women (44.52%) receiving influenza vaccines during pregnancy, and the Macon region had the 
lowest percentage of women receiving the vaccine (7.91%). .25% of women who completed a 
birth worksheet in 2015 and also received an influenza vaccine did not reside in a Georgia 
county so they were grouped together as “out-of-state”. Women who received an influenza 
vaccine, but did not list a county of residence totaled .03% of all women vaccinated.  
 Next, the researcher examined the correlation that mother’s age at time of infant’s birth 
has on influenza vaccine uptake. Table 6 illustrates the positive trendline between increase in age 
and vaccine uptake. Women in the 25 – 34 years old age group had the highest rates of 
vaccination among all age groups. The largest increase in vaccination rates occurred between the 
21 – 24 age group and the 25 – 34 age group.  
 The logistic regression model in Table 8 predicts influenza vaccine uptake among 
pregnant women by age, education level, race, perinatal region of residence, and receipt of 
prenatal care. Mother’s age at time of infant’s birth (OR = 0.13, 95% CI: 0.12, 0.15) and race 
(OR = 0.15, 95% CI: 0.10, 0.19) were associated with vaccine uptake. Pregnant women are 13% 
more likely to be vaccinated depending on their age. Table 6 also shows that age is positively 
associated with vaccine uptake. Race is also associated with vaccine uptake, with pregnant 
women being 15% more likely to receive the vaccine depending on race. Education level, 
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perinatal region of residence, and receipt of prenatal care was not significantly associated with an 
increase in influenza vaccine uptake among pregnant women.  
Discussion  
 This analysis of the 2015 Georgia VEIS Birth Worksheet reports on some of the leading 
factors that are associated with influenza vaccine uptake among women during pregnancy. There 
is no data available for comparison, yet, as the question about influenza vaccination during 
pregnancy was added to the Birth Worksheet on July 1st, 2014 (Figure 2). The results of this 
study reveal that Georgia falls short of the Healthy People 2020 goal of having 80% of pregnant 
women vaccinated against influenza [32]. Only 13.39 percent of women who completed a Birth 
Worksheet in 2015 responded that they were vaccinated during pregnancy. This means over 86% 
of pregnant women were unprotected from seasonal influenza, putting their and their infants’ 
health at risk.  
There is a higher likelihood that Georgian women will receive the vaccine if they are 
white or black. Of all respondents who identified as American Indian/Alaskan Native, 15.92% 
received the influenza vaccine while pregnant. This rate is second only to white women (16.51% 
of white respondents being vaccinated). American Indians receive free healthcare through the 
Indian Health Service and reduced-cost health insurance through the Affordable Care Act (ACA) 
[33], thus increasing the likelihood they will get a vaccine because the cost-barrier is not there. 
Age of the mother at the time of infant’s birth is also associated with vaccine uptake. As age 
increases from 18 – 34 years, so does influenza vaccine uptake. There is a decrease in 
vaccination from the 25 – 34 age group to the 35 – 49 age group (60.16% to 16.16%). This may 
be due to women fearing the increased chance of complications during pregnancy as they get 
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older. Providers can use this information to target the 35 - 49 age group that is more at-risk for 
influenza complications due to their age and pregnancy status.  
It was unexpected to the researcher that as mothers’ level of education increased, so did 
receipt of influenza vaccine. As education increases, typically so does level of knowledge on 
health, general well-being, and preventative care [34]. Factors such as education, are associated 
with health outcomes. Education level and employment status are root causes that influence 
income and poverty which in turn influences health disparities in Georgia [35]. A large gap 
exists between those with high and low education levels in the US, and education contributes to 
increased health literacy, preventative care, and the ability to navigate healthcare [36]. The 
results imply that as Georgia women gain more education, they understand the importance of 
preventative healthcare and the risk influenza could have on themselves and their infant, during 
and after pregnancy. Women with higher levels of education may also have access to healthcare 
providers that offer preventative measures like influenza vaccines or explain the risks of not 
being vaccinated. 
A large proportion of Georgia’s population resides in the metro Atlanta area, or for the 
purposes of this study, the Atlanta perinatal region. This region encompasses 46 of Georgia’s 
159 counties, more than any other perinatal region. Of those respondents who reported the 
Atlanta region as their residence, only 10.32% were vaccinated during pregnancy. The 
vaccination rate even fell behind those who were vaccinated in the out-of-state group (11.14%). 
These results are concerning because 57.7% of study participants reported living in the Atlanta 
perinatal region. More research as to why the most populous perinatal region in Georgia has the 
lowest rate of vaccine uptake needs to be done. Hopefully, the findings of the present study can 
guide future research into the issue. 
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The rate of women receiving prenatal care in Georgia in 2015 was high at 88.71%. 
Unfortunately, of these women who had at least one prenatal care visit, just 14.87% of them 
received an influenza vaccine. These women were in the presence of healthcare professionals, 
but were either not offered the vaccine, they declined the vaccine, or perhaps did not learn of the 
importance of influenza vaccination during pregnancy. A concerning barrier to vaccination found 
in a study of Georgia PRAMS data was that “Doctor did not mention influenza vaccination” 
[29]. A major barrier discussed in a previous section of this paper is concern about the safety of 
the vaccine by both pregnant patients and healthcare employees [5]. Evidence exists on the 
safety of the influenza vaccine during pregnancy for both mother and baby. The vaccine even 
protects infants for up to the first six months of life [3]. Evidence needs to be more readily 
available to pregnant women and healthcare providers so that this barrier can be eliminated.  
Limitations. There are a few limitations to consider when interpreting the results of this 
study. First, the data was subject to recall bias. Women who have recently given birth may not 
remember if and when they were vaccinated against influenza. There is also the small risk they 
may not recall if they received prenatal care. Second, there is the risk of self-report bias; women 
reporting they received a vaccine or prenatal care because they perceive that to be the socially 
acceptable answer even if they did not receive either the vaccine or prenatal care. Lastly, the 
study reported on women ages 18 – 49. Women younger than 18 and older than 49 were 
excluded, so the data is not representative of all women in the state of Georgia. The most 
commonly used childbearing age range was used for the purpose of this study.  
Implications. This study emphasizes the need for public health promotion of influenza 
vaccination during pregnancy in the state of Georgia. Georgia’s rates of vaccination are below 
the national average which is at about 50% [8]. Pregnant Georgians are at risk of costly 
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influenza-related complications that could result in hospital admission or even death. The cost-
effectiveness of vaccinated pregnant women outweighs the disease-burden influenza has on this 
population and the rest of society [30].  
Public health interventions should primarily target prenatal care providers because the 
clear majority of women received prenatal care in 2015. Providers can influence a woman’s 
decision because their opinions are highly regarded during pregnancy. Women are generally 
more concerned about their health and how it affects their baby’s health while they are pregnant. 
Most women who did receive an influenza vaccine while pregnant also received prenatal care. 
This implies that those women were offered the vaccine by a prenatal care provider or learned 
about the benefits of vaccination during a prenatal appointment.  
Useful demographic information was found in this study. The researcher found that most 
of vaccine recipients were white, between 25 – 34 years of age, and had a college degree. Race, 
education level, and age are all influential in influenza vaccine uptake among pregnant women. 
Promotion efforts could target those groups that had the lowest rates of vaccination. Educating 
women about the two-for-one benefit that the vaccine provides will increase the likelihood they 
will receive the influenza vaccine [3].  
Future research should further examine another potential factor that is associated with 
vaccine uptake: the socioeconomic status (SES) of pregnant women in Georgia. Perhaps cost is a 
barrier to vaccination for those with low SES. This could be a large barrier to overcome, but it 
could be targeted by programs and clinics that offer reduced healthcare to those in need. Also, 
comparing data across years could also help strengthen the associations between factors such as 
age, race, education level, prenatal care, and perinatal region of residence with influenza vaccine 
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uptake. This research would be on hold until the Georgia Department of Public Health is ready to 
release 2016 VEIS Birth Worksheet data. 
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Table 1 
Sample Characteristics   
   
Variable N (%) 
Race   
Asian 6,093 4.68 
Black/African American 46,122 35.44 
Hawaiian/Pacific Islander 202 0.15 
White 68,900 52.95 
American Indian/Alaskan 
Native 559 0.43 
Other 4,851 3.73 
Unknown 3,406 2.62 
Age   
18-20 11,545 8.87 
21-24 26,788 20.58 
25-34 71,724 55.12 
35-49 20,076 15.43 
Education Level   
Less than High School Degree 17,393 13.37 
High School Degree/GED 63,518 48.81 
College Degree 46,827 35.98 
Unknown 2,395 1.84 
Perinatal Region of Residence  
Atlanta Region 75,168 57.77 
Augusta Region 13,539 10.4 
Columbus Region 10,791 8.29 
Macon Region 7,389 5.69 
Albany Region 9,280 7.13 
Savannah Region 13,538 10.4 
Out-of-state 395 0.3 
Unknown 33 0.02 
Total 130,133  
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Table 2 
Sample Characteristics by Vaccine 
Uptake     
      
 
                                Vaccine Uptake, N 
(%)  
Variable Yes %           No               %       Total 
Race      
Asian 634 10.40 5,459 89.59 6,093 
Black/African American 4,624 10.02 41,498 89.97 46,122 
Hawaiian/Pacific Islander 23 11.39 179 88.61 202 
White 11,373 16.51 57,527 83.49 68,900 
American Indian/Alaskan Native 89 15.92 470 84.08 559 
Other 583 12.02 4,268 87.98 4,851 
Unknown 102 2.99 3,304 97 3,406 
Age      
18-20 1,188 10.29 10,357 89.71 11,545 
21-24 2,847 10.63 23,941 89.37 26,788 
25-34 10,477 14.61 61,247 85.39 71,724 
35-49 2,816 14.03 17,160 85.47 20,076 
Education Level      
Less than High School Degree 1,477 8.49 15,916 91.51 17,393 
High School Degree/GED 6,970 10.97 56,548 89.03 63,518 
College Degree 8,893 18.99 37,934 81 46,827 
Unknown 88 3.67 2,307 96.32 2,395 
Perinatal Region of Residence      
Atlanta Region 7,759 10.32 67,409 89.68 75,168 
Augusta Region 2,323 17.16 11,216 82.84 13,539 
Columbus Region 1,472 13.64 9,319 86.36 10,791 
Macon Region 1,379 18.66 6,010 81.34 7,389 
Albany Region 1,694 18.25 7,586 81.74 9,280 
Savannah Region 2,752 20.33 10,786 79.67 13,538 
Out-of-state 44 11.14 351 88.86 395 
Unknown 5 15.15 28 84.85 33 
Total 17,428 13.39    
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Table 3 
Prevalence of Vaccine Uptake by Receipt of Prenatal Care 
      
  
Prenatal 
Care N % 
Vaccine Yes     17,163 14.87 
      
Vaccine No       98,280 85.13 
      
Total       115,443 88.71 
      
 
Table 4 
Prevalence of Vaccination (by Trimester) among Women Who Received Prenatal Care and Influenza Vaccine 
   Prenatal Care N %  
First Trimester    4,768 27.78  
        
Second Trimester    5,910 34.44  
        
Third Trimester    6,124 35.68  
        
Other     361 2.1  
        
Total     17,163 13.18  
*Other includes responses women gave other than 1st, 2nd, or 3rd trimesters  
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Table 5 
 
Prevalence of Influenza Vaccine Uptake by Perinatal Region of Residence 
             Influenza Vaccine Uptake                                                 N %   
Atlanta Region   7,759 44.52   
        
Augusta Region   2,323 13.33   
        
Columbus Region   1,472 8.47   
        
Macon Region   1,379 7.91   
        
Albany Region   1,694 9.72   
        
Savannah Region   2,752 15.97   
        
Out-of-State   44 .25   
        
Unknown   5 .03   
        
Total    17,428 13.39   
* Highest and lowest rates are bolded 
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Table 6 
Pearson’s r Correlation Coefficient 
  age 
vaccine 
YES 
age 1  
vaccine 
YES 0.387487 1 
   
 
Scatter plot with data trendline illustrating a positive correlation between increase in age and 
influenza vaccine uptake  
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Table 7 
Univariate analysis of Mother’s Age at time of Infant’s Birth 
Mothers Age at time of birth  
  
Mean 28.26833317 
Standard Error 0.015973881 
Median 28 
Mode 28 
Standard Deviation 5.762409996 
Sample Variance 33.20536896 
Kurtosis -0.52969523 
Skewness 0.298663634 
Range 31 
Minimum 18 
Maximum 49 
Sum 3678643 
Count 130133 
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Table 8 
Logistic Regression Model for Influenza Vaccine Uptake    
   95% CI 
Variable OR Estimate  Lower Upper 
Mother's Age 0.13   0.12 0.15 
          
Education Level 0.13   -0.06 0.33 
          
Race 0.15   0.1 0.19 
          
Perinatal Region of Residence 0.09   0.07 0.11 
          
Receipt of Prenatal Care 0.07   0.06 0.07 
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Figure 1 
Source: Georgia Department of Public Health. (2017, June 21). Regional Perinatal Centers. 
Retrieved June 25, 2017, from https://dph.georgia.gov/RPC 
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Figure 2 
 
51. Vaccinations during pregnancy (Note trimester)     TDAP   Trimester ______       
 Flu   Trimester ______         Other   Trimester _______      None    
__________________________________________________________________ 
 
Source: State of Georgia Birth Worksheet. (2014). Retrieved May 19, 2017, from 
http://www.gamidwife.com/pdf/BIRTH_WORKSHEET-2014.pdf 
 
 
 
 
 
 
 
 
 
 
 
 
 
